Current management of severe ulcerative colitis

[1]  M. Regueiro,et al.  Infliximab for Hospitalized Patients With Severe Ulcerative Colitis , 2006, Journal of clinical gastroenterology.

[2]  T. Ahmad,et al.  Genetics of inflammatory bowel disease: the role of the HLA complex. , 2006, World journal of gastroenterology.

[3]  W. Sandborn,et al.  Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  D. Goldstein,et al.  ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. , 2006, Human molecular genetics.

[5]  Camille Ripoll,et al.  Hypothesis: Chemotaxis in Escherichia coli Results from Hyperstructure Dynamics , 2006, Journal of Molecular Microbiology and Biotechnology.

[6]  Paul Rutgeerts,et al.  Infliximab for induction and maintenance therapy for ulcerative colitis. , 2005, The New England journal of medicine.

[7]  R. Ciccocioppo,et al.  Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats. , 2005, World journal of gastroenterology.

[8]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[9]  Å. Danielsson,et al.  Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. , 2005, Gastroenterology.

[10]  Z. Cohen,et al.  Prevention of Postoperative Abdominal Adhesions by a Novel, Glycerol/Sodium Hyaluronate/Carboxymethylcellulose-Based Bioresorbable Membrane: A Prospective, Randomized, Evaluator-Blinded Multicenter Study , 2005, Diseases of the colon and rectum.

[11]  T. Shimoyama,et al.  Leukocytapheresis (LCAP) for Management of Fulminant Ulcerative Colitis with Toxic Megacolon , 2005, Digestive Diseases and Sciences.

[12]  M. Schwartz,et al.  Is Endoscopy Necessary for the Measurement of Disease Activity in Ulcerative Colitis? , 2005, The American Journal of Gastroenterology.

[13]  K. Soares-Weiser,et al.  Cyclosporine A for induction of remission in severe ulcerative colitis. , 2005, The Cochrane database of systematic reviews.

[14]  D. Jewell,et al.  Ciclosporin use in acute ulcerative colitis: a long-term experience , 2005, European journal of gastroenterology & hepatology.

[15]  A. Sonnenberg,et al.  Period and generation effects on mortality from idiopathic inflammatory bowel disease , 1989, Digestive Diseases and Sciences.

[16]  R. Caprilli,et al.  Risk factors in toxic megacolon , 1980, Digestive Diseases and Sciences.

[17]  K. Lance,et al.  Utility of cells exfoliated onto the esophagoscope as an aid in the diagnosis of esophageal carcinoma , 2005, The American Journal of Digestive Diseases.

[18]  S. Travis,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.

[19]  S. Travis.  Predicting outcome in severe ulcerative colitis. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[20]  T. Longacre,et al.  Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis: A Case-Control Study , 2004, The American journal of surgical pathology.

[21]  K. Schmid,et al.  Endoscopic decompression in “toxic megalcolon” , 2004, Surgical Endoscopy.

[22]  E. Loftus.  Mortality in inflammatory bowel disease: peril and promise. , 2003, Gastroenterology.

[23]  R. Hubbard,et al.  Mortality in inflammatory bowel disease: a population-based cohort study. , 2003, Gastroenterology.

[24]  P. Munkholm,et al.  Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. , 2003, Gastroenterology.

[25]  P. Beck,et al.  A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management , 2003, American Journal of Gastroenterology.

[26]  P. Rutgeerts,et al.  Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. , 2003, Gastroenterology.

[27]  A. Forbes,et al.  Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial , 2003, Gut.

[28]  T. Longacre,et al.  Cytomegalovirus infection in steroid-refractory ulcerative colitis , 2003 .

[29]  D. D. de Jong,et al.  Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials. , 2003, The Netherlands journal of medicine.

[30]  J. Lewis,et al.  Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis , 2002, American Journal of Gastroenterology.

[31]  R. Caprilli,et al.  GI distension in severe ulcerative colitis , 2002, American Journal of Gastroenterology.

[32]  C. Fife,et al.  Hyperbaric oxygen therapy for severe ulcerative colitis. , 2001, Journal of clinical gastroenterology.

[33]  M. Imbriaco,et al.  Toxic megacolon: role of CT in evaluation and detection of complications. , 2001, Clinical imaging.

[34]  L. Mortelmans,et al.  Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. , 2001, Gastroenterology.

[35]  G. Pietrosi,et al.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis , 2001, American Journal of Gastroenterology.

[36]  R. Caprilli,et al.  Multiple organ dysfunction in ulcerative colitis , 2000, American Journal of Gastroenterology.

[37]  Carbonnel,et al.  Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis , 2000, Alimentary pharmacology & therapeutics.

[38]  R. Löfberg,et al.  Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis , 1998, European journal of gastroenterology & hepatology.

[39]  R. Pounder,et al.  A simple clinical colitis activity index , 1998, Gut.

[40]  F. Casellas,et al.  Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. , 1995, Gastroenterology.

[41]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[42]  M. Panos,et al.  Toxic megacolon: the knee-elbow position relieves bowel distension. , 1993, Gut.

[43]  T. Yao,et al.  An index of disease activity in patients with ulcerative colitis. , 1992, The American journal of gastroenterology.

[44]  D. Jewell,et al.  Small bowel gas in severe ulcerative colitis. , 1991, Gut.

[45]  D. Sachar,et al.  Management of severe hemorrhage in ulcerative colitis. , 1990, American journal of surgery.

[46]  D. Present,et al.  Medical decompression of toxic megacolon by "rolling". A new technique of decompression with favorable long-term follow-up. , 1988, Journal of clinical gastroenterology.

[47]  E. Bergqvist,et al.  Induction of and adaptation to olsalazine induced intestinal volume load. , 1988, Scandinavian journal of gastroenterology. Supplement.

[48]  F. T. de Dombal,et al.  Perforation of the intestine in inflammatory bowel disease. An OMGE survey. , 1988, Scandinavian journal of gastroenterology. Supplement.

[49]  R. Caprilli,et al.  Early recognition of toxic megacolon. , 1987, Journal of clinical gastroenterology.

[50]  E. Feuer,et al.  Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. , 1987, Journal of clinical gastroenterology.

[51]  D. Jewell,et al.  Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. , 1986, Gut.

[52]  J. Lennard-jones,et al.  Controlled trial of bowel rest in the treatment of severe acute colitis. , 1986, Gut.

[53]  H. Janowitz,et al.  Systemic corticosteroid therapy of ulcerative colitis. , 1985, Gastroenterology.

[54]  D. Schrag,et al.  Outcome of toxic dilatation in ulcerative and Crohn's colitis. , 1985, Journal of clinical gastroenterology.

[55]  P. Shoenberg.  An Experience of Ulcerative Colitis , 1983, British Journal of Psychiatry.

[56]  J. Goldberg,et al.  Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis: A prospective, randomized, double-blind clinical trial , 1983 .

[57]  J. Goldberg,et al.  Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. , 1983, Gastroenterology.

[58]  C. Bartram,et al.  Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features. , 1980, Gastroenterology.

[59]  S. Truelove,et al.  FURTHER EXPERIENCE IN THE TREATMENT OF SEVERE ATTACKS OF ULCERATIVE COLITIS , 1978, The Lancet.

[60]  R. Caprilli,et al.  Salt-losing diarrhoea in idiopathic proctocolitis. , 1978, Scandinavian journal of gastroenterology.

[61]  J. Lennard-jones,et al.  A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis. , 1977, Scandinavian journal of gastroenterology.

[62]  R. Caprilli,et al.  Blood pH: a test for assessment of severity in proctocolitis. , 1976, Gut.

[63]  A. McKendrick,et al.  DENTAL CARIES AND SUGAR INTAKE , 1975, The Lancet.

[64]  C. Spicer,et al.  Assessment of severity in colitis: a preliminary study. , 1975, Gut.

[65]  D. Jewell,et al.  Intensive intravenous regimen for severe attacks of ulcerative colitis. , 1974, Lancet.

[66]  Y. Wolloch,et al.  Pitfalls in the surgical management of fulminating ulcerative colitis , 1972, Diseases of the colon and rectum.

[67]  Corticosteroid therapy in ulcerative colitis. , 1970, The New England journal of medicine.

[68]  W. Card,et al.  An experience of ulcerative colitis. I. Toxic dilation in 55 cases. , 1969, Gastroenterology.

[69]  M. Chapman,et al.  Definition of megacolon in colitis. , 1969, Gut.

[70]  S. Truelove,et al.  Cortisone in ulcerative colitis; final report on a therapeutic trial. , 1955, British medical journal.

[71]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .

[72]  S. Truelove,et al.  ULCERATIVE COLITIS COURSE AND PROGNOSIS , 1950 .

[73]  T. L. Hardy,et al.  ULCERATIVE COLITIS , 1933, British medical journal.